Myasthenia Gravis, Generalized
32
13
17
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 32 trials
100.0%
+13.4% vs benchmark
28%
9 trials in Phase 3/4
75%
6 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (32)
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Markers of Favorable Response to Complement Inhibitors Therapy
Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)
Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis
A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Study of Telitacicept in Generalized Myasthenia Gravis